Additionally, the ME/CFS cohort showed a significant increase in TRPM7 co-localization with actin for the TRPM7 antagonism treatment compared with HCs (p < 0.01) (Figure 4). Here, TRPM7 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.